Donald Trump

Trump wants drug commercials to include prices. These five companies have the most at stake
Trump wants drug commercials to include prices. These five companies have the most at stake
Stat
Donald Trump
drug ads
drug pricing
Pfizer
AbbVie
Eli Lilly
Amgen
Allergan
Flag link:
Trump rule mandating drug prices in TV ads might be unconstitutional
Trump rule mandating drug prices in TV ads might be unconstitutional
Yahoo
drug pricing
Donald Trump
television ads
drug ads
PhRMA
Flag link:
Confronting pharma, Trump admin seeks price disclosure in drug ads
Confronting pharma, Trump admin seeks price disclosure in drug ads
Biopharma Dive
drug pricing
drug ads
Donald Trump
Alex Azar
HHS
Flag link:
Trump to sign law allowing FTC to scrutinize biosimilar deals
Trump to sign law allowing FTC to scrutinize biosimilar deals
Biopharma Dive
Donald Trump
biosimilars
antitrust
FTC
Flag link:
Will Trump's Pharma Shaming Bring Down Drug Prices? Not Likely, Poll Says
Will Trump's Pharma Shaming Bring Down Drug Prices? Not Likely, Poll Says
Forbes
Donald Trump
drug pricing
Flag link:
Experts split on impact of drug price hike freezes
Experts split on impact of drug price hike freezes
Medical Marketing and Media
drug pricing
Donald Trump
Flag link:
Senators question whether Giuliani's influence scored Purdue Pharma leniency from feds
Senators question whether Giuliani's influence scored Purdue Pharma leniency from feds
Fierce Pharma
Purdue Pharma
opioids
Donald Trump
Rudy Giuliani
Flag link:
Trump administration, Senate move forward on pricing transparency proposals
Trump administration, Senate move forward on pricing transparency proposals
Fierce Pharma
Donald Trump
Senate
drug pricing
Flag link:
The Trump administration can’t decide whether drug industry middlemen are the enemy — or part of the solution
The Trump administration can’t decide whether drug industry middlemen are the enemy — or part of the solution
Stat
Donald Trump
drug pricing
PBMs
Flag link:
Trump seeks federal opioid lawsuit, DOJ aims to slash manufacturing quotas
Trump seeks federal opioid lawsuit, DOJ aims to slash manufacturing quotas
Biopharma Dive
DOJ
opioids
Donald Trump
Flag link:
Generic Drugmakers Struggle Despite U.S. Push for Copycats
Generic Drugmakers Struggle Despite U.S. Push for Copycats
Yahoo/Bloomberg
generics
Donald Trump
drug pricing
Flag link:
Johnson & Johnson CEO Alex Gorsky dines with Trump as president promises ‘substantial’ drug price cuts
Johnson & Johnson CEO Alex Gorsky dines with Trump as president promises ‘substantial’ drug price cuts
Fierce Pharma
JNJ
Pharma CEOs
Alex Gorsky
Donald Trump
drug pricing
Flag link:
Trump’s new tone with drug makers: gratitude
Trump’s new tone with drug makers: gratitude
Stat
Donald Trump
drug pricing
Flag link:
Two Pharma Giants Successfully Navigate a Challenging Climate
Two Pharma Giants Successfully Navigate a Challenging Climate
Yahoo/Zacks.com
Donald Trump
drug pricing
Merck
Amgen
Flag link:
AstraZeneca joins U.S. drug price freeze for rest of 2018
AstraZeneca joins U.S. drug price freeze for rest of 2018
Reuters
AstraZeneca
drug pricing
Donald Trump
Flag link:
Merck’s price cuts are flashy, but no more benevolent than Pfizer’s freeze: analysts
Merck’s price cuts are flashy, but no more benevolent than Pfizer’s freeze: analysts
Fierce Pharma
Merck
Pfizer
drug pricing
Donald Trump
Flag link:
Roche has taken the Trump pledge, joining Pfizer, Novartis and Merck in promising to hold the line on drug prices
Roche has taken the Trump pledge, joining Pfizer, Novartis and Merck in promising to hold the line on drug prices
Endpoints
Roche
Merck
Pfizer
Novartis
drug pricing
Donald Trump
Flag link:
Merck lowers prices of some drugs after Trump calls out industry
Merck lowers prices of some drugs after Trump calls out industry
Yahoo/Reuters
Merck
drug pricing
Donald Trump
hepatitis C
Flag link:
Trump thanks Novartis, Pfizer for not raising drug prices
Trump thanks Novartis, Pfizer for not raising drug prices
Yahoo/Reuters
Donald Trump
drug pricing
Novartis
Pfizer
Flag link:
Under the gun for Cohen deal, Novartis CEO Vas Narasimhan hits the brakes on US drug price hikes
Under the gun for Cohen deal, Novartis CEO Vas Narasimhan hits the brakes on US drug price hikes
Endpoints
Novartis
Vas Narasimhan
drug pricing
Donald Trump
Michael Cohen
Flag link:

Pages